CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −58,424 | 29,670 | ||
| 2026-05-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +48,565 | $30.93 | $1.5M | 48,565 |
| 2026-05-01 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −48,565 | $54.02 | $2.6M | 0 |
| 2026-05-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −48,565 | 0 | ||
| 2026-04-30 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +2,141 | $30.93 | $66K | 2,141 |
| 2026-04-30 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −2,141 | $54.01 | $116K | 0 |
| 2026-04-30 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −2,141 | 48,565 | ||
| 2026-04-29 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +22,544 | $30.93 | $697K | 22,544 |
| 2026-04-29 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −22,544 | $54.01 | $1.2M | 0 |
| 2026-04-29 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −22,544 | 50,706 | ||
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +431,904 | $10.36 | $4.5M | 431,904 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +51,750 | $30.93 | $1.6M | 483,654 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −74,635 | $50.43 | $3.8M | 409,019 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −113,673 | $51.47 | $5.9M | 295,346 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −243,596 | $52.02 | $12.7M | 51,750 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −51,750 | $54.02 | $2.8M | 0 |
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −431,904 | 0 | ||
| 2026-04-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −51,750 | 73,250 | ||
| 2026-04-28 | Quart Barry D Director | Option exercise 10b5-1 | +13,099 | $14.33 | $188K | 25,645 |
| 2026-04-28 | Quart Barry D Director | Sale 10b5-1 | −13,099 | $50.10 | $656K | 12,546 |
Page 12 of 74 · 1,467 trades